This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Zhou L, Yong X, Zhou J, Xu J, Wang C. Clinicopathological analysis of five cases of NUT midline carcinoma, including one with the gingiva. BioMed Res Int. 2020;2020:9791208. DOI: 10.1155/2020/9791208.Search in Google Scholar
Agaimy A, Fonseca I, Martins C, Thway K, Barrette R, Harrington KJ, et al. NUT carcinoma of the salivary glands. Clinicopathologic and molecular analysis of three cases and a survey of NUT expression in salivary gland carcinomas. American J Surg Pathol. 2018;42(7):877-84. DOI: 10.1097/PAS.0000000000001046.Search in Google Scholar
Chau NG, Ma C, Danga K, Al-Sayegh H, Nardi V, Barrette R, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr. 2019;4(2):pkz094. DOI: 10.1093/jncics/pkz094.Search in Google Scholar
Mills AF, Lanfranchi M, Wein RO, Mukand-Cerro I, Pilichowska M, Cowan J, et al. NUT midline carcinoma: a case report with a novel translocation and review of the literature. Head Neck Pathol. 2014;8(2):182-6. DOI: 10.1007/ s12105-013-0479-3.Search in Google Scholar
Liu S, Ferzli G. NUT carcinoma: a rare and devastating neoplasm. BMJ Case Reports. 2018;2018:bcr-2018. DOI: 10.1136/bcr-2018-226526.Search in Google Scholar
Hsieh MS, French CA, Liang CW, Hsiao CH. NUT midline carcinoma: case report and review of the literature. Int J SurgPathol. 2011;19(6):808-12. DOI: 10.1177/1066896909353600.Search in Google Scholar
Shiota H, Barral S, Buchou T, Tan M, Coute Y, Charbonnier G, et al. NUT directs p300-dependent, genome-wide H4 hyperacetylation in male germ cells. Cell Rep. 2018;24(13):3477-87.e6. DOI: 10.1016/j.celrep.2018.08.069.Search in Google Scholar
Napolitano M, Venturelli M, Molinaro E, Toss A. NUT midline carcinoma of the head and neck: current perspectives. Onco Targets Ther. 2019;12:3235-44. DOI: 10.2147/OTT.S173056.Search in Google Scholar
French CA, Rahman S, Walsh EM, Kuhnle S, Grayson AR, Lemieux ME, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4(8):928-41. DOI: 10.1158/2159-8209.CD-14-0014.Search in Google Scholar
French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27(15):2237-42. DOI: 10.1038/sj.onc.1210852.Search in Google Scholar
Alekseyenko AA, Walsh EM, Zee BM, Pakozdi T, Hsi P, Lemieux ME, et al. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114(21):E4184-92. DOI: 10.1073/pnas.1702086114.Search in Google Scholar
Lee JK, Louzada S, An Y, Kim SY, Kim S, Youk J, et al. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Ann Oncol. 2017;28(4):890-7. DOI: 10.1093/annonc/mdw686.Search in Google Scholar
Wang S, Li J, Tong W, Li H, Feng Q, Teng B. Advances in the pathogenesis and treatment of nut carcinoma: a narrative review. Transl Cancer Res. 2020;9(10):6505-15. DOI: 10.21037/tcr-20-1884.Search in Google Scholar
Grayson AR, Walsh EM, Cameron MJ, Godec J, Ashworth T, Ambrose JM, et al. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene. 2014;33(13):1736-42. DOI: 10.1038/onc.2013.126.Search in Google Scholar
Giridhar P, Mallick S, Kashyap L, Rath GK. Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases. Eur Arch Otorhinolaryngol. 2018;275(3):815-21. DOI: 10.1107/s00405-018-4882-y.Search in Google Scholar
do Amparo Veloso Magalhães M, Carvalho Batista NJ, and Grivicich I. Nut mid-line carcinoma: a case report. International Journal of Development Research. 2016;06(10):9719-21.Search in Google Scholar
Wei X, Teng X, Zhang Y, Cheng M, Chen G. Case report: NUT carcinoma in an elderly woman with unique morphology and immunophenotype highlights a diagnostic pitfall. Transl Cancer Res. 2022;11(6):1850-60. DOI: 10.21037/tcr-22-364.Search in Google Scholar
Kakkar A, Antony VM, Irugu DVK, Adhikari N, Jain D. NUT midline carcinoma: a series of five cases, including one with unusual clinical course. Head Neck Pathol. 2018;12(2):230-6. DOI: 10.1007/s12105-017-0858-2.Search in Google Scholar
Minato H, Kobayashi E, Nakada S, Kurose N, Tanaka M, Tanaka Y, et al. Sinonasal NUT carcinoma: clinicopathological and cytogenetic analysis with autopsy findings. Hum Pathol. 2018;71:157-65. DOI: 10.1016/j.humpath.2017.10.011.Search in Google Scholar
Lee T, Cho J, Baek CH, Son YI, Jeong HS, Chung MK, et al. Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review. Head Neck. 2020;42(5):924-38. DOI: 10.1002/hed.26067.Search in Google Scholar
Vakani PN, Maheshwari J, Maheshwari M, Shah B. Sinonasal NUT midline carcinoma: A new histological entity. Indian J Pathol Microbiol. 2020;63(1):103-5. DOI: 10.4103/IJPM.IJPM_373_19.Search in Google Scholar
Saik WN, Da Forno P, Thway K, Khurram SA. NUT carcinoma arising from the parotid gland: a case report and review of the literature. Head Neck Pathol. 2021;15(3):1064-8. DOI: 10.1007/s12105-020-01254-9.Search in Google Scholar
Patil VM, Toshniwal A, Noronha V, Joshi A, Menon N, Banavali S, et al. NUT midline carcinoma. Clin Oncol (R Coll Radiol). 2019;31(10):732. DOI: 10.1016/j.clon.2019.06.012.Search in Google Scholar
Rajan A. A hard nut to crack: Case report on nut midline carcinoma-a rare sino-nasal malignancy. JMSCR. 2020;8(5):342-5. DOI: 10.18535/jmscr/v8i5.63.Search in Google Scholar
Aryakrishna SL, Kumar R, Rafi M, Mathews A. Nut midline carcinoma-nasal cavity-A case report. JMSCR. 2020;8(6):437-40. DOI: 10.18535/jmscr/v8i6.83.Search in Google Scholar
Patel SA, Singer B, Shen C, Zanation AM, Yarbrough WG, Weiss J. A case of metastatic NUT carcinoma with prolonged response on gemcitabine and nabpaclitaxel. Clin Case Rep. 2021;9:e04616. DOI: 10.1002/ccr3.4616.Search in Google Scholar
Elkhatib SK, Neilsen BK, Sleightholm RL, Baine MJ, Zhen W. A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature. J Med Case Reports. 2019;13(1):57. DOI: 10.1186/s13256-019-2015-x.Search in Google Scholar
Albrecht T, Harms A, Roessler S, Goeppert B. NUT carcinoma in a nutshell: A diagnosis to be considered more frequently. Pathol Res Pract. 2019;215(6):152347. DOI: 10.1016/j.prp.2019.01.043.Search in Google Scholar
Klijanienko J, Le Tourneau C, Rodriguez J, Caly M, theocharis S. Cytological features of NUT midline carcinoma arising in sino-nasal tract and parotid gland: Report of two new cases and review of the literature. Diagn Cytopathol. 2016;44(9):753-6. DOI: 10.1002/dc.23506.Search in Google Scholar
Arimizu K, Hirano G, Makiyama C, Matsuo M, Sasaguri T, Makiyama A. NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report. BMC Cancer. 2018;18:1134. DOI: 10.1186/s12885-018-5087-x.Search in Google Scholar
Seim NB, Philips RHW, Schoenfield L, Teknos TN, Rocco JW, Agrawal A, et al. NUT midline carcinoma of the sublingual gland: Clinical presentation and review. Head Neck Pathol. 2017;11(4):460-8. DOI: 10.1007/s12105-017-0809-y.Search in Google Scholar
Oliveira LJC, Gongora ABL, Latancia MT, Barbosa FG, Gregorio JVAM, Testagrossa LA, et al. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report. J Med Case Rep. 2019;13:279. DOI: 10.1186/ s13256-019-2213-6.Search in Google Scholar
D’Souza JN, Notz G, Bogdasarian RN, Cognetti DM, Curry JM, Rosen MR, et al. Orbital involvement by NUT midline carcinoma. Ophthalmic Plast Reconstr Surg. 2015;31(6):e147-50. DOI: 10.1097/IOP.0000000000000179.Search in Google Scholar
Ding T, Wang Y, Zhao T, Xu Z, Gao W, Cui Z, et al. NUT midline carcinoma in the right orbit: a case report. Cancer Biol Ther. 2019;20(8):1091-6. DOI: 10.1080/15384047.2019.1598761.Search in Google Scholar
Maher OM, Christensen AM, Yedururi S, Bell D, Tarek N. Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer. 2015;62(4):715-7. DOI: 10.1002/pbc.25350.Search in Google Scholar
Storck S, Kennedy AL, Marcus KJ, Teot L, Vaughn J, Gnekow AK, et al. Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach. Pediatr Hematol Oncol. 2017;34(4):231-7. DOI: 10.1080/08880018.2017.1363839.Search in Google Scholar
Andreasen S, French CA, Josiassen M, Hahn CH, Kiss K. NUT carcinoma of the sublingual gland. Head Neck Pathol. 2016;10(3):362-6. DOI: 10.1007/s12105-015-0672-7.Search in Google Scholar
Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA. Successful treatment of a child with t(15;19)-positive tumor. Pediatr Blood Cancer. 2007;49(7):1015-7. DOI: 10.1102/pbc.20755.Search in Google Scholar
, 